6-((2-(5-aminopentylamino)quinolin-4-yl)methyl)-7-(3-hydroxypropylthio)-4-isobutyl-2-methyl-2,6-dihydro-1H-pyrrolo[3,4-d]pyridazin-1-one

ID: ALA3818095

PubChem CID: 127052809

Max Phase: Preclinical

Molecular Formula: C29H40N6O2S

Molecular Weight: 536.75

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)Cc1nn(C)c(=O)c2c(SCCCO)n(Cc3cc(NCCCCCN)nc4ccccc34)cc12

Standard InChI:  InChI=1S/C29H40N6O2S/c1-20(2)16-25-23-19-35(29(38-15-9-14-36)27(23)28(37)34(3)33-25)18-21-17-26(31-13-8-4-7-12-30)32-24-11-6-5-10-22(21)24/h5-6,10-11,17,19-20,36H,4,7-9,12-16,18,30H2,1-3H3,(H,31,32)

Standard InChI Key:  BKAOCYWXHJNRPN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 38 41  0  0  0  0  0  0  0  0999 V2000
   -6.4133   -6.8760    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1764   -5.5904    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4385   -4.2619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8936   -6.8644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1714   -5.5451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9345   -4.2596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9443   -3.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5870   -3.7544    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7158   -5.2111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2779   -7.8944    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1996   -2.9687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7004   -2.9802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3090   -1.9460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.2921   -4.0242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0029   -7.9211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5797   -6.1883    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1630   -5.6929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9749   -6.6715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3917   -6.1761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3015   -6.9585    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2907   -2.9981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2964   -1.4973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2964    1.4973    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6111    0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6111   -0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9122    1.4966    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2109    0.7445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5121    1.4924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8109    0.7403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1121    1.4882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.4109    0.7361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.4513    1.3341    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2964   -1.4973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5929   -0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5929    0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2964    1.4973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  2  0
  3  6  1  0
  5  4  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9  5  2  0
  4 10  2  0
  3 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
  1 15  1  0
  9 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
  8 21  1  0
 21 22  1  0
 22 34  1  0
 33 23  1  0
 23 24  2  0
 24 25  1  0
 25 22  2  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 33  2  0
M  END

Alternative Forms

  1. Parent:

    ALA3818095

    ---

Associated Targets(Human)

SLC16A1 Tchem Monocarboxylate transporter 1 (146 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 536.75Molecular Weight (Monoisotopic): 536.2933AlogP: 4.55#Rotatable Bonds: 14
Polar Surface Area: 110.99Molecular Species: BASEHBA: 9HBD: 3
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 10.21CX LogP: 3.95CX LogD: 1.31
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.16Np Likeness Score: -0.73

References

1. Nair RN, Mishra JK, Li F, Tortosa M, Yang C, Doherty JR, Cameron M, Cleveland JL, Roush WR, Bannister TD..  (2016)  Exploiting the co-reliance of tumours upon transport of amino acids and lactate: Gln and Tyr conjugates of MCT1 inhibitors.,  (5): [PMID:27347360] [10.1039/c5md00579e]
2. Murray, Clare M CM and 26 more authors.  2005-12  Monocarboxylate transporter MCT1 is a target for immunosuppression.  [PMID:16370372]
3. Wang, Hui H and 5 more authors.  2014-09-11  Synthesis and structure-activity relationships of pteridine dione and trione monocarboxylate transporter 1 inhibitors.  [PMID:25068893]
4. Nair, Reji N and 9 more authors.  2016-05-01  Exploiting the co-reliance of tumours upon transport of amino acids and lactate: Gln and Tyr conjugates of MCT1 inhibitors.  [PMID:27347360]

Source